Last reviewed · How we verify
Chemo Plus Far
At a glance
| Generic name | Chemo Plus Far |
|---|---|
| Sponsor | Morphotek |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement. (NA)
- Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01) (PHASE3)
- The Influence of Chemotherapy on Position Sense
- Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy (PHASE2)
- Infusion System for Hepatic Cancer (NA)
- PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy (PHASE3)
- PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy (NA)
- Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |